3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
34
Carcinoma, Non-Small-Cell Lung
26
Breast Neoplasms
25
Lung Neoplasms
24
Colonic Neoplasms
18
Head and Neck Neoplasms
16
Rectal Neoplasms
14
Sarcoma
10
Prostatic Neoplasms
10
Neoplasm Metastasis
9
Pancreatic Neoplasms
8
Neoplasms
7
Mouth Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Ovarian Neoplasms
6
Glioblastoma
6
Adenomatous Polyposis Coli
6
Precancerous Conditions
5
Neuroblastoma
5
Liver Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Oropharyngeal Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Interventions
Colonoscopy
16
Water
3
Aspirin
3
Ursodeoxycholic Acid
2
Sunitinib
2
Narrow Band Imaging
2
Folic Acid
2
Endoscopic Mucosal Resection
2
Calcium Carbonate
2
pegvisomant
1
defactinib
1
S-Adenosylmethionine
1
Reference Standards
1
Polyethylene Glycols
1
Octreotide
1
Occult Blood
1
Methods
1
Mesalamine
1
Mass Screening
1
Injections
1
Indocyanine Green
1
Endoscopy
1
Drug Evaluation
1
Diet, Fat-Restricted
1
Diagnostic Tests, Routine
1
Cholecystectomy
1
Cholecalciferol
1
Celecoxib
1
Calcitriol
1
Cabergoline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Adenoma
×
Celecoxib
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled